J. Alan Crunkleton

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Vibrato Medical, Inc. is a private company based in an undisclosed location. The American company has developed the first wearable therapeutic ultrasound device for the noninvasive treatment of peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI). The device is designed to promote vasodilation, collateral vessel growth, angiogenesis, and restore perfusion. Vibrato Medical's leadership team has extensive experience in developing and commercializing medical devices and is supported by an experienced board of directors and recognized clinical leaders in the field of PAD. The company's mission is to be the preferred therapeutic system for patients with reduced tissue perfusion. The company was founded by Bobak Azamian and Babak Nazer, and the CEO is Juliana Elstad.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA.

Actimed Therapeutics Ltd. is a British clinical stage specialty pharmaceutical company that focuses on bringing innovation to the treatment of muscle wasting disorders. Actimed is based in Ascot, UK. Actimed's lead product, ACM-001 (S-pindolol), targets multiple biological pathways that drive cachexia and has generated promising proof of concept data in a phase II clinical trial in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The company is currently preparing for further clinical studies of cachexia in these two cancer types. The company was founded in 2017 by Stefan D. Anker and Andrew Justin Stewart Coats, two world-leading physicians in muscle wasting research, together with Yann Colardelle, a professional in communications and medical education.

CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA.

Bacchus Vascular, Inc. manufactures and sells medical devices. It provides treatments for peripheral vascular diseases. The company was founded by Nellix Michael and Thomas J. Fogarthy in 1999 and is headquartered in Santa Clara, CA.

G3 Pharmaceuticals, Inc. is a development-stage biopharmaceutical company. It manufactures and develops galectin-3 biology, cardiovascular pharmaceutical and carbohydrate drugs. The company is headquartered in Lexington, MA.